To counteract the consequences of L-NAME and/or L-arginine administration with the disturbed hemostasis, we administered the stable gastric pentadecapeptide BPC 157 [1,2,1026] not only due to its special effect on hemostasis [1,2], but also owing to a particular beneficial combining [1,2,1014], wound healing capacity [1,2,1017] and particular interaction with NO-system [14,15,1826]
Nutritional Approach A relevant aspect in the management of the patients with PWS is the adherence to a diet starting from the first months of life to favor a regular body growth and, subsequently, to cope with the incipient hyperphagia and to prevent or treat the excess of weight throughout the life span [6, 7, 89]
doi:10.1186/s40814-022-00990-9 DISCLAIMER: These statements have not been approved by the Food and Drug Administration
1B, 2B), with or without fat suppression (Fig
If you have Medicare or Medicaid, copay cards are not an option
No geographic or economic restrictions were applied